Source link : https://www.newshealth.biz/health-news/biden-proposes-coverage-of-obesity-drugs-in-medicare-medicaid/
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like semaglutide (Wegovy) or tirzepatide (Zepbound) under a regulation proposed Tuesday by the Centers for Medicare & Medicaid Services (CMS). Current law “excludes drugs used for weight loss from Medicare prescription drug coverage,” CMS administrator Chiquita Brooks-LaSure said on […]
Author : News Health
Publish date : 2024-11-26 19:31:23
Copyright for syndicated content belongs to the linked Source.
inHealth